Pienta Kenneth 4
4 · Cue Biopharma, Inc. · Filed Mar 29, 2022
Insider Transaction Report
Form 4
Pienta Kenneth
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2022-03-25+40,000→ 40,000 totalExercise: $5.01Exp: 2032-03-24→ Common Stock (40,000 underlying)
Footnotes (1)
- [F1]1. This stock option grant becomes exercisable in eight equal semi-annual installments beginning September 25, 2022.